Your browser doesn't support javascript.
loading
Distribution and Drug Resistance of Carbapenem-resistant Citrobacter Freundii from 2012 to 2014 / 昆明医科大学学报
Journal of Kunming Medical University ; (12): 35-38, 2016.
Artigo em Chinês | WPRIM | ID: wpr-514111
ABSTRACT
Objective To investigate the distribution and susceptibility of carbapenem resistant citrobacter freundii for rational antimicrobial therapy.Methods The C.freumdii were collected between January 2011 and December 2014 from inpatients.The minimum inhibitory concentration (MIC) were detected by an automated analyzer (VITEK 2) to analyze the characteristic of tested bacteria.Results (1) Of the 21 strains of carbapenemresistant citrobacter freundii,95% were collected from urine,among which most of the strains were isolated from the Department of Transplantology (66.7%) and Urology (19%);(2) Antimicrobials Susceptibility test showed that Citmbacter freund were highly resistant to Cephalosporins and relevant beta-lactamase inhibitors.Even carbapenem were highly resistant.Imipenem had a resistance rate of 90% (95% confidence interval70 to 99),Meropenem 85.7% (95% confidence interval64 to 97),The drug resistance rate to Amikacin was only 4.8%,followed by Nitrofuran toin (10.5%) and Fosfomycin (15%).Conclusions Carbapenem resistant citrobacter freundii,which often causes urinary tract infection in our hospital,was characterized by multi-drug resistant (MDR).Monitoring of the Citrobaeter freundii should be strengthened to control the prevalence of drug resistance.

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Journal of Kunming Medical University Ano de publicação: 2016 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Journal of Kunming Medical University Ano de publicação: 2016 Tipo de documento: Artigo